Drug Type Small interfering RNA |
Synonyms siRNA 3033, siRNA3033 |
Target |
Mechanism JAK1 inhibitors(Tyrosine-protein kinase JAK1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | US | Aldena Therapeutics, Inc.Startup | 04 Nov 2023 |
Autoimmune Diseases | Preclinical | US | 04 Nov 2023 | |
Inflammation | Preclinical | US | 04 Nov 2023 | |
Inflammation | Preclinical | US | Aldena Therapeutics, Inc.Startup | 04 Nov 2023 |